首页> 外文期刊>EXCLI Journal >Quantification of three-dimensional structures in liver tissue: bile canalicular and sinusoidal networks
【24h】

Quantification of three-dimensional structures in liver tissue: bile canalicular and sinusoidal networks

机译:肝组织三维结构的定量:胆管和正弦波网络

获取原文
获取外文期刊封面目录资料

摘要

Unpredicted hepatotoxicity represents the most frequent reason for withdrawal of drugs from the market (Godoy et al., 2013). Therefore, large efforts are currently undertaken to establish improved techniques to predict hepatotoxicity (Shimizu et al., 2009; O’Brien et al., 2006; Okwa et al., 2013; Oloyede et al., 2013; Lu et al., 2013; Godoy et al., 2009). The perhaps most intensive activities in this field of research can be observed in establishment of hepatocyte in vitro systems (Godoy et al., 2013; Hewitt et al., 2007; Ilkavets et al., 2013; Hengstler et al., 2012, 2014; Hammad et al., 2013; Hammad, 2013). One of the concepts of this type of in vitro research is that stress responses to chemicals are similar in vitro and in vivo. Therefore, activation of stress response pathways in vitro may indicate a potential hazard (Jennings, 2013; Vinken et al., 2014). Although hepatocyte in vitro systems have promoted our understanding of mechanisms (Meyer et al., 2011; Schug et al., 2013; Godoy et al., 2010, 2012; Zellmer et al., 2010; Hengstler et al., 2014) it has also become clear that a full replacement of animal experiments for toxicity testing will not be possible within the next one or two decades (Adler et al., 2011; Hammad, 2013). Reasons are difficulties to include xenobiotic metabolism into in vitro tests, to model interactions between cell types, to extrapolate from in vivo doses to in vitro concentrations and to simulate the consequences of long term exposure in vitro (Tice et al., 2013; Ghallab, 2013). However, one additional aspect may currently be underestimated: we still know too little about mechanisms of in vivo toxicity to establish in vitro systems in a way that the most critical in vivo processes are recapitulated. Although this may seem paradoxical, progress in replacement of animal experiments currently depends on progress in understanding the mechanisms of toxicity in vivo.
机译:不可预知的肝毒性是药物退出市场的最常见原因(Godoy等,2013)。因此,目前正在进行巨大的努力来建立预测肝毒性的改良技术(Shimizu等,2009; O'Brien等,2006; Okwa等,2013; Oloyede等,2013; Lu等, 2013; Godoy等,2009)。可以在建立肝细胞体外系统中观察到该研究领域中最密集的活动(Godoy等,2013; Hewitt等,2007; Ilkavets等,2013; Hengstler等,2012,2014 ; Hammad等,2013; Hammad,2013)。这类体外研究的概念之一是,对化学物质的应激反应在体外和体内都是相似的。因此,体外应激反应途径的激活可能表明存在潜在危险(Jennings,2013; Vinken等,2014)。尽管肝细胞体外系统促进了我们对机制的理解(Meyer等,2011; Schug等,2013; Godoy等,2010,2012; Zellmer等,2010; Hengstler等,2014),同样清楚的是,在接下来的一到二十年内不可能完全替代动物实验进行毒性测试(Adler等,2011; Hammad,2013)。原因是难以将异源代谢纳入体外测试,建模细胞类型之间的相互作用,从体内剂量推断到体外浓度以及模拟体外长期暴露的后果(Tice等人,2013; Ghallab, 2013)。但是,目前可能低估了另一个方面:我们仍然对体内毒性机制了解得很少,无法以最关键的体内过程得以概括的方式建立体外系统。尽管这似乎是自相矛盾的,但替代动物实验的进展目前取决于了解体内毒性机理的进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号